DocCheck AG

XTRA:AJ91 Voorraadrapport

Marktkapitalisatie: €46.4m

DocCheck Beheer

Beheer criteriumcontroles 4/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Frank Antwerpes

Algemeen directeur

€244.7k

Totale compensatie

Percentage CEO-salaris75.5%
Dienstverband CEOno data
Eigendom CEO55.7%
Management gemiddelde ambtstermijn5.3yrs
Gemiddelde ambtstermijn bestuur25.8yrs

Recente managementupdates

What Can We Conclude About DocCheck's (ETR:AJ91) CEO Pay?

Dec 07
What Can We Conclude About DocCheck's (ETR:AJ91) CEO Pay?

Recent updates

We Think You Can Look Beyond DocCheck's (ETR:AJ91) Lackluster Earnings

Apr 19
We Think You Can Look Beyond DocCheck's (ETR:AJ91) Lackluster Earnings

DocCheck (ETR:AJ91) Has Some Way To Go To Become A Multi-Bagger

Aug 04
DocCheck (ETR:AJ91) Has Some Way To Go To Become A Multi-Bagger

Estimating The Fair Value Of DocCheck AG (ETR:AJ91)

May 20
Estimating The Fair Value Of DocCheck AG (ETR:AJ91)

The Trend Of High Returns At DocCheck (ETR:AJ91) Has Us Very Interested

Nov 06
The Trend Of High Returns At DocCheck (ETR:AJ91) Has Us Very Interested

Returns On Capital Are A Standout For DocCheck (ETR:AJ91)

Mar 03
Returns On Capital Are A Standout For DocCheck (ETR:AJ91)

If You Like EPS Growth Then Check Out DocCheck (ETR:AJ91) Before It's Too Late

Jan 18
If You Like EPS Growth Then Check Out DocCheck (ETR:AJ91) Before It's Too Late

Do DocCheck's (ETR:AJ91) Earnings Warrant Your Attention?

Aug 26
Do DocCheck's (ETR:AJ91) Earnings Warrant Your Attention?

Should DocCheck AG (ETR:AJ91) Be Part Of Your Dividend Portfolio?

May 02
Should DocCheck AG (ETR:AJ91) Be Part Of Your Dividend Portfolio?

Investors Shouldn't Overlook DocCheck's (ETR:AJ91) Impressive Returns On Capital

Apr 18
Investors Shouldn't Overlook DocCheck's (ETR:AJ91) Impressive Returns On Capital

Should You Be Adding DocCheck (ETR:AJ91) To Your Watchlist Today?

Mar 23
Should You Be Adding DocCheck (ETR:AJ91) To Your Watchlist Today?

Is DocCheck AG's (ETR:AJ91) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Mar 04
Is DocCheck AG's (ETR:AJ91) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Did You Participate In Any Of DocCheck's (ETR:AJ91) Incredible 419% Return?

Feb 14
Did You Participate In Any Of DocCheck's (ETR:AJ91) Incredible 419% Return?

Could The DocCheck AG (ETR:AJ91) Ownership Structure Tell Us Something Useful?

Jan 27
Could The DocCheck AG (ETR:AJ91) Ownership Structure Tell Us Something Useful?

Under The Bonnet, DocCheck's (ETR:AJ91) Returns Look Impressive

Jan 10
Under The Bonnet, DocCheck's (ETR:AJ91) Returns Look Impressive

If You Like EPS Growth Then Check Out DocCheck (ETR:AJ91) Before It's Too Late

Dec 22
If You Like EPS Growth Then Check Out DocCheck (ETR:AJ91) Before It's Too Late

What Can We Conclude About DocCheck's (ETR:AJ91) CEO Pay?

Dec 07
What Can We Conclude About DocCheck's (ETR:AJ91) CEO Pay?

DocCheck AG's (ETR:AJ91) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Nov 22
DocCheck AG's (ETR:AJ91) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Analyse CEO-vergoeding

Hoe is Frank Antwerpes's beloning veranderd ten opzichte van DocCheck's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

€2m

Mar 31 2024n/an/a

€2m

Dec 31 2023€245k€185k

€2m

Sep 30 2023n/an/a

€4m

Jun 30 2023n/an/a

€6m

Mar 31 2023n/an/a

€6m

Dec 31 2022€250k€190k

€6m

Sep 30 2022n/an/a

€7m

Jun 30 2022n/an/a

€7m

Mar 31 2022n/an/a

€9m

Dec 31 2021€250k€190k

€11m

Sep 30 2021n/an/a

€12m

Jun 30 2021n/an/a

€13m

Mar 31 2021n/an/a

€11m

Dec 31 2020€211k€151k

€9m

Sep 30 2020n/an/a

€7m

Jun 30 2020n/an/a

€4m

Mar 31 2020n/an/a

€4m

Dec 31 2019€245k€185k

€3m

Sep 30 2019n/an/a

€3m

Jun 30 2019n/an/a

€3m

Mar 31 2019n/an/a

€3m

Dec 31 2018€244k€184k

€2m

Sep 30 2018n/an/a

€2m

Jun 30 2018n/an/a

€2m

Mar 31 2018n/an/a

€2m

Dec 31 2017€237k€177k

€2m

Compensatie versus markt: De totale vergoeding ($USD 266.17K ) Frank } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de German markt ($USD 490.17K ).

Compensatie versus inkomsten: De vergoeding van Frank is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Frank Antwerpes

no data

Tenure

€244,721

Compensatie

Dr. Frank Nicolas Antwerpes serves as the Chief Executive Officer at DocCheck Guano AG. He served as the Chief Executive Officer of DocCheck Medizinbedarf und Logistik GmbH. Dr. Antwerpes serves as Preside...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Frank Antwerpes
President of the Management Board & CEOno data€244.72k55.71%
€ 25.9m
Philip Stadtmann
CFO & Member of Management Board5.3yrs€232.41kgeen gegevens
Thilo Kolzer
COO & Member of Management Board5.3yrs€234.81kgeen gegevens
Jens Knoop
CTO & Member of Management Board5.3yrs€195.80kgeen gegevens

5.3yrs

Gemiddelde duur

Ervaren management: Het managementteam van AJ91 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.3 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Joachim Pietzko
Chairman of the Supervisory Board25.8yrs€19.20kgeen gegevens
Winfried Leimeister
Deputy Chairwoman of the Supervisory Board25.8yrs€9.60kgeen gegevens
Karin Immenroth
Chief Data & Analytics Officer and Member of Supervisory Board2.5yrs€9.60kgeen gegevens

25.8yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van AJ91 zijn ervaren en ervaren (gemiddelde ambtstermijn van 25.8 jaar).